Changing late prognosis of acute myocardial infarction: Impact on management of ventricular arrhythmias in the era of reperfusion and the implantable cardioverter-defibrillator

Circulation

Volumn 107, Issue 7, 2003, Pages 941-946

  Hohnloser, Stefan H ^a   Gersh, Bernard J ^b  

^a GOETHE UNIVERSITY   (Germany)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; AMBULATORY MONITORING; BAYES THEOREM; CARDIOVASCULAR RISK; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; DEFIBRILLATOR; EXERCISE TEST; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; HEART VENTRICLE ARRHYTHMIA; HUMAN; MALE; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; SIGNAL AVERAGED ELECTROCARDIOGRAPHY; SUDDEN DEATH;

ARRHYTHMIA; BAYES THEOREM; CLINICAL TRIALS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PRACTICE GUIDELINES; PROGNOSIS; RISK FACTORS; TIME FACTORS;

EID: 0037465447     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000054211.00668.9B     Document Type: Review

References (33)

1. Myerburg RJ, Mitrani R, Interian A Jr, et al. Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact. Circulation. 1998;97:1514-1521.
2. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. 1996;335:1933-1940.
3. Buxton AE, Lee KL, Fisher JD, et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial. N Engl J Med. 1999;341:1882-1890.
4. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337:1576-1583.
5. Berman DS, Garcia EV, Maddahi J. Thallium-201 myocardial scintigraphy in the detection and evaluation of coronary artery disease. In: Berman DS, Mason DT. eds. Clinical Nuclear Cardiology. New York, NY: Grune & Stratton; 1981:49-106.
6. Rouleau JL, Talajic M, Sussex B, et al. Myocardial infarction patients in the 1990s: their risk factors, stratification and survival in Canada: the Canadian Assessment of Myocardial Infarction (CAMI) Study. J Am Coll Cardiol. 1996;27:1119-1127.
7. Kim CB, Braunwald E. Potential benefits of late reperfusion of infarcted myocardium: the open artery hypothesis. Circulation. 1993;88:2426-2436.
8. Vatterott PJ, Hammill SC, Bailey KR, et al. Late potentials on signal-averaged electrocardiograms and patency of the infarct-related artery in survivors of acute myocardial infarction. J Am Coll Cardiol. 1991;17:330-337.
9. Hohnloser SH, Franck P, Klingenheben T, et al. Open infarct artery, late potentials, and other prognostic factors in patients after acute myocardial infarction in the thrombolytic era: a prospective trial. Circulation. 1994;90:1747-1756.
10. The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med. 1983;309:331-336.
11. Hohnloser SH, Klingenheben T, Zabel M, et al. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era. J Am Coll Cardiol. 1999;33:1895-1902.
12. Schwartz PJ, La Rovere MT, Vanoli E. Autonomic nervous system and sudden cardiac death: experimental basis and clinical observations for post-myocardial infarction risk stratification. Circulation. 1992;85(suppl I):I-77-I-91.
13. Mortara A, Specchia G, La Rovere MT, et al. Patency of infarct-related artery: effect of restoration of anterograde flow on vagal reflexes. ATRAMI (Automatic Tone and Reflexes After Myocardial Infarction) Investigators. Circulation. 1996;93:1114-1122.
14. Lind P, Hintze U, Moller M, et al. Thrombolytic therapy preserves vagal activity early after acute myocardial infarction. Scand Cardiovasc J. 2001;35:92-95.
15. Kawalsky DL, Garratt KN, Hammill SC, et al. Effect of infarct-related artery patency and late potentials on late mortality after acute myocardial infarction. Mayo Clin Proc. 1997;72:414-421.
16. Tavazzi L, Volpi A. Remarks about postinfarction prognosis in light of the experience with the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI) trials. Circulation. 1997;95:1341-1345.
17. Villella A, Maggioni AP, Villella M, et al. Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 data-base. Gruppo Italiano per lo Studio della Sopravvivenza Nell'Infarto. Lancet. 1995;346:523-529.
18. Cerisano G, Bolognese L, Buonamici P, et al. Prognostic implications of restrictive left ventricular filling in reperfused anterior acute myocardial infarction. J Am Coll Cardiol. 2001;37:793-799.
19. Maggioni AP, Zuanetti G, Franzosi MG, et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation. 1993;87: 312-322.
20. Gomes JA, Winters SL, Martinson M, et al. The prognostic significance of quantitative signal-averaged variables relative to clinical variables, site of myocardial infarction, ejection fraction and ventricular premature beats: a prospective study. J Am Coll Cardiol. 1989:13:377-384.
21. Denniss AR, Richards DA, Cody DV, et al. Pyrognostic significance of ventricular tachycardia and fibrillation induced at programmed stimulation and delayed potentials detected on the signal-averaged electrocardiograms of survivors of acute myocardial infarction. Circulation. 1986;74:731-745.
22. Bourke JP, Young AA, Richards DA, et al. Reduction in incidence of inducible ventricular tachycardia after myocardial infarction by treatment with streptokinase during infarct evolution. J Am Coll Cardiol. 1990; 16:1703-1710.
23. Savard P, Rouleau JL, Ferguson J, et al. Risk stratification after myocardial infarction using signal-averaged electrocardiographic criteria adjusted for sex, age, and myocardial infarction location. Circulation. 1997;96: 202-213.
24. Copie X, Hnatkova K, Staunton A, et al. Predictive power of increased heart rate versus depressed left ventricular ejection fraction and heart rate variability for risk stratification after myocardial infarction: results of a two-year follow-up study. J Am Coll Cardiol. 1996;27:270-276.
25. Zuanetti G, Neilson JM, Latini R, et al. Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era: the GISSI-2 results. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Circulation. 1996; 94:432-436.
26. La Rovere MT, Bigger JT Jr, Marcus FI, et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet. 1998;351:478-484.
27. La Rovere MT, Pinna GD, Hohnloser SH, et al. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation. 2001;103:2072-2077.
28. Naccarella F, Lepera G, Rolli A. Arrhythmic risk stratification of post-myocardial infarction patients. Curr Opin Cardiol. 2000;15:1-6.
29. Carney RM, Blumenthal JA, Stein PK, et al. Depression, heart rate variability, and acute myocardial infarction. Circulation. 2001;104:2024-2028.
30. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation. 1995;91:999-1005.
31. Domanski MJ, Sakseena S, Epstein AE, et al. Relative effectiveness of the implantable cardioverter-defibrillator and antiarrhythmic drugs in patients with varying degrees of left ventricular dysfunction who have survived malignant ventricular arrhythmias. AVID Investigators. Antiarrhythmics Versus Implantable Defibrillators. J Am Coll Cardiol. 1999;34:1090-1095.
32. Solomon SD, Glynn RJ, Greaves S, et al. Recovery of ventricular function after myocardial infarction in the reperfusion era: the Healing and Early Afterload Reducing Therapy study. Ann Intern Med. 2001;134: 451-458.
33. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-883.